Vincent J, Elliott H L, Meredith P A, Hughes D M, Reid J L
Eur J Clin Pharmacol. 1985;29(3):301-6. doi: 10.1007/BF00544084.
The effect of cimetidine treatment on the pharmacokinetics and pharmacodynamics of single doses of trimazosin was studied in 6 normotensive volunteers. Co-administration of cimetidine did not significantly affect the overall magnitude of the hypotensive effect of trimazosin. However, the time profile of the blood pressure response was significantly modified particularly with attenuation of the delayed component. Co-administration of cimetidine did not alter alpha 1-adrenoceptor antagonism by trimazosin. There was no significant change in the clearance and volume of distribution of trimazosin but there was a significant reduction in the area under the concentration-time curve for the metabolite, 1-hydroxy-trimazosin. The reduction in the AUC of 1-hydroxy-trimazosin corresponds in time with the attenuation of the delayed hypotensive response. This is consistent with the suggestion that the delayed hypotensive response is related to an active metabolite, probably 1-hydroxytrimazosin.
在6名血压正常的志愿者中研究了西咪替丁治疗对单剂量曲马唑嗪药代动力学和药效学的影响。西咪替丁与曲马唑嗪合用并未显著影响曲马唑嗪降压作用的总体强度。然而,血压反应的时间曲线发生了显著改变,尤其是延迟成分的减弱。西咪替丁与曲马唑嗪合用并未改变曲马唑嗪对α1-肾上腺素能受体的拮抗作用。曲马唑嗪的清除率和分布容积没有显著变化,但代谢产物1-羟基曲马唑嗪的浓度-时间曲线下面积显著降低。1-羟基曲马唑嗪AUC的降低与延迟降压反应的减弱在时间上相对应。这与延迟降压反应与一种活性代谢产物(可能是1-羟基曲马唑嗪)有关的观点一致。